全文获取类型
收费全文 | 3469篇 |
免费 | 314篇 |
国内免费 | 9篇 |
专业分类
3792篇 |
出版年
2022年 | 46篇 |
2021年 | 79篇 |
2020年 | 31篇 |
2019年 | 46篇 |
2018年 | 65篇 |
2017年 | 52篇 |
2016年 | 86篇 |
2015年 | 181篇 |
2014年 | 201篇 |
2013年 | 209篇 |
2012年 | 250篇 |
2011年 | 266篇 |
2010年 | 161篇 |
2009年 | 123篇 |
2008年 | 169篇 |
2007年 | 185篇 |
2006年 | 155篇 |
2005年 | 163篇 |
2004年 | 149篇 |
2003年 | 134篇 |
2002年 | 132篇 |
2001年 | 109篇 |
2000年 | 104篇 |
1999年 | 70篇 |
1998年 | 30篇 |
1997年 | 22篇 |
1996年 | 17篇 |
1995年 | 12篇 |
1994年 | 20篇 |
1993年 | 16篇 |
1992年 | 42篇 |
1991年 | 46篇 |
1990年 | 29篇 |
1989年 | 44篇 |
1988年 | 16篇 |
1987年 | 33篇 |
1986年 | 31篇 |
1985年 | 25篇 |
1984年 | 24篇 |
1983年 | 19篇 |
1982年 | 22篇 |
1981年 | 16篇 |
1980年 | 14篇 |
1979年 | 17篇 |
1978年 | 20篇 |
1977年 | 11篇 |
1976年 | 14篇 |
1974年 | 13篇 |
1973年 | 11篇 |
1972年 | 10篇 |
排序方式: 共有3792条查询结果,搜索用时 15 毫秒
81.
Xiao Yu Wei Lu Chan Way Ng Shuoyu Xu Yao Wu Shili Chen Yuren Gao Yijian Zhang Qingqing Zhang Yuzhen Xu Yingbin Liu Sheng Li 《Journal of cellular and molecular medicine》2020,24(13):7670-7674
Gallbladder carcinoma (GBC) is a vicious and invasive disease. The major challenge in the clinical treatment of GBC is the lack of a suitable prognosis method. Chemokine receptors such as CXCR3, CXCR4 and CXCR7 play vital roles in the process of tumour progression and metastasis. Their expression levels and distribution are proven to be indicative of the progression of GBC, but are hard to be decoded by conventional pathological methods, and therefore, not commonly used in the prognosis of GBC. In this study, we developed a computer‐aided image analysis method, which we used to quantitatively measure the expression levels of CXCR3, CXCR4 and CXCR7 in the nuclei and cytoplasm of glandular and interstitial cells from a cohort of 55 GBC patients. We found that CXCR3, CXCR4 and CXCR7 expressions are associated with the clinicopathological variables of GBC. Cytoplasmic CXCR3, nuclear CXCR7 and cytoplasmic CXCR7 were significant predictive factors of histology invasion, whereas cytoplasmic CXCR4 and nuclear CXCR4 were significantly correlated with T and N stage and were associated with the overall survival and disease‐free survival. These results suggest that the quantification and localisation of CXCR3, CXCR4 and CXCR7 expressions in different cell types should be considered using computer‐aided assessment to improve the accuracy of prognosis in GBC. 相似文献
82.
Joe Carver Domingos Ng Michelle Zhou Peggy Ko Dejin Zhan Mandy Yim David Shaw Brad Snedecor Michael W. Laird Steven Lang Amy Shen Zhilan Hu 《Biotechnology progress》2020,36(4):e2967
Historically, therapeutic protein production in Chinese hamster ovary (CHO) cells has been accomplished by random integration (RI) of expression plasmids into the host cell genome. More recently, the development of targeted integration (TI) host cells has allowed for recombination of plasmid DNA into a predetermined genomic locus, eliminating one contributor to clone-to-clone variability. In this study, a TI host capable of simultaneously integrating two plasmids at the same genomic site was used to assess the effect of antibody heavy chain and light chain gene dosage on antibody productivity. Our results showed that increasing antibody gene copy number can increase specific productivity, but with diminishing returns as more antibody genes are added to the same TI locus. Random integration of additional antibody DNA copies in to a targeted integration cell line showed a further increase in specific productivity, suggesting that targeting additional genomic sites for gene integration may be beneficial. Additionally, the position of antibody genes in the two plasmids was observed to have a strong effect on antibody expression level. These findings shed light on vector design to maximize production of conventional antibodies or tune expression for proper assembly of complex or bispecific antibodies in a TI system. 相似文献
83.
84.
85.
Bobby G. Ng Paulina Sosicka François Fenaille Annie Harroche Sandrine Vuillaumier-Barrot Mindy Porterfield Zhi-Jie Xia Shannon Wagner Michael J. Bamshad Marie-Christine Vergnes-Boiteux Sophie Cholet Stephen Dalton Anne Dell Thierry Dupré Mathieu Fiore Stuart M. Haslam Yohann Huguenin Tadahiro Kumagai Hudson H. Freeze 《American journal of human genetics》2021,108(6):1040-1052
86.
Ee Xien Ng Ming Wang Shu Hui Neo Ching Ann Tee Chia-Hung Chen Krystyn J. Van Vliet 《Biotechnology journal》2021,16(3):2000048
Microcarriers are synthetic particles used in bioreactor-based cell manufacturing of anchorage-dependent cells to promote proliferation at efficient physical volumes, mainly by increasing the surface area-to-volume ratio. Mesenchymal stromal cells (MSCs) are adherent cells that are used for numerous clinical trials of autologous and allogeneic cell therapy, thus requiring avenues for large-scale cell production at efficiently low volumes and cost. Here, a dissolvable gelatin-based microcarrier is developed for MSC expansion. This novel microcarrier shows comparable cell attachment efficiency and proliferation rate when compared to several commercial microcarriers, but with higher harvesting yield due to the direct dissolution of microcarrier particles and thus reduced cell loss at the cell harvesting step. Furthermore, gene expression and in vitro differentiation suggest that MSCs cultured on gelatin microcarriers maintain trilineage differentiation with similar adipogenic differentiation efficiency and higher chondrogenic and osteogenic differentiation efficiency when compared to MSCs cultured on 2D planar polystyrene tissue culture flask; on the contrary, MSCs cultured on conventional microcarriers appear to be bipotent along osteochondral lineages whereby adipogenic differentiation potential is impeded. These results suggest that these gelatin microcarriers are suitable for MSC culture and expansion, and can also potentially be extended for other types of anchorage-dependent cells. 相似文献
87.
Ng Chu Xin Le Cheng Foh Tor Yin Sim Lee Sau Har 《International journal of peptide research and therapeutics》2021,27(4):2757-2775
International Journal of Peptide Research and Therapeutics - Bioactive peptides have emerged as promising therapeutic alternatives in pharmaceutical industry, especially to fight cancer. Here we... 相似文献
88.
Michelle M. Ng Holly C. Dippold Matthew D. Buschman Christopher J. Noakes Seth J. Field 《Molecular biology of the cell》2013,24(6):796-808
GOLPH3 is a phosphatidylinositol-4-phosphate (PI4P) effector that plays an important role in maintaining Golgi architecture and anterograde trafficking. GOLPH3 does so through its ability to link trans-Golgi membranes to F-actin via its interaction with myosin 18A (MYO18A). GOLPH3 also is known to be an oncogene commonly amplified in human cancers. GOLPH3L is a GOLPH3 paralogue found in all vertebrate genomes, although previously it was largely uncharacterized. Here we demonstrate that although GOLPH3 is ubiquitously expressed in mammalian cells, GOLPH3L is present in only a subset of tissues and cell types, particularly secretory tissues. We show that, like GOLPH3, GOLPH3L binds to PI4P, localizes to the Golgi as a consequence of its PI4P binding, and is required for efficient anterograde trafficking. Surprisingly, however, we find that perturbations of GOLPH3L expression produce effects on Golgi morphology that are opposite to those of GOLPH3 and MYO18A. GOLPH3L differs critically from GOLPH3 in that it is largely unable to bind to MYO18A. Our data demonstrate that despite their similarities, unexpectedly, GOLPH3L antagonizes GOLPH3/MYO18A at the Golgi. 相似文献
89.